Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from University of Alabama at Birmingham evaluating an integrative liver-targeted therapy that combines Tauroursodeoxycholate with Tradit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tauroursodeoxycholate (tauroursodeoxycholic acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetic Macular Edema (DME) | Phase 2 | Status: NOT_YET_RECRUITING